DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.6701
-0.0599 (-8.21%)
At close: May 12, 2025, 4:00 PM
0.6667
-0.0034 (-0.51%)
After-hours: May 12, 2025, 7:46 PM EDT
DURECT Employees
DURECT had 21 employees as of December 31, 2024. The number of employees decreased by 37 or -63.79% compared to the previous year.
Employees
21
Change (1Y)
-37
Growth (1Y)
-63.79%
Revenue / Employee
$96,714
Profits / Employee
-$396,381
Market Cap
20.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DRRX News
- 6 weeks ago - DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 7 weeks ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - PRNewsWire
- 3 months ago - DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 3 months ago - DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - PRNewsWire
- 6 months ago - DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PRNewsWire
- 6 months ago - DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire